Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market […]
GE HealthCare taps Amazon Web Services to build generative AI for medical use
Jakub Porzycki | Nurphoto | Getty Images GE HealthCare on Thursday announced it is teaming up with Amazon Web Services to build new generative artificial intelligence models and tools that […]
Here are 5 stocks that are buys right here, right now
Let’s say you just joined the Club, and you are trying to figure out which stocks we think are buyable right now, right here. Ideally, what I would like members […]
Jim Cramer says GE Healthcare's unwarranted post-earnings plunge is a buying opportunity
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re […]
Google partners with Bayer on new AI product for radiologists
Google Cloud and the German health-care company Bayer on Tuesday announced they are building an artificial intelligence-powered platform that aims to help radiologists diagnose patients and work through cases more […]
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign […]
Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re […]
The news hitting a portfolio health-care name actually removes an overhang on the stock
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. U.S. stocks were mixed Wednesday […]
What Eli Lilly investors can learn from the slow launch of a competitor's drug
Club holding Eli Lilly is expecting to get approval for its Alzheimer’s treatment in the coming weeks, but investors looking for immediate financial success should temper their expectations. On its […]
Jim Cramer praises GE following U.S. regulatory approval to develop nuclear fuel
CNBC’s Jim Cramer called out General Electric as a winner in the industrial sector for the strides it’s making in nuclear power. GE’s Verona Nuclear Fuel business said Wednesday it […]